Vaccine Maitri

Last updated

Countries that received doses of the Indian-made Covaxin as of 6 March 2021 Indian-vaccine-to-covid-19.svg
Countries that received doses of the Indian-made Covaxin as of 6 March 2021

Vaccine Maitri (English:Vaccine Friendship) [1] is a humanitarian initiative undertaken by the Indian government to provide COVID-19 vaccines to countries around the world. [2] The government started providing vaccines from 20 January 2021. As of 9 May 2021, India had delivered around 66.3 million doses of vaccines to 95 countries. [3] Of these, 10.7 million doses were gifted to 47 countries by the Government of India. The remaining 54 million were supplied by the Serum Institute of India under its commercial and COVAX obligations. In late March 2021, the Government of India temporarily froze exports of the Covishield, citing India's own COVID crisis and the domestic need for these vaccines. [4] The Health Minister of India, Mr. Mansukh Mandaviya announced in September that India will resume the export of vaccines from October to the rest of the world. [5] [6]

Contents

Oxford AstraZeneca COVID-19 vaccine (Indian version) 2021 L.jpeg

200,000 doses of COVID-19 vaccines were gifted by India to the UN peacekeepers on 27 March to be distributed to all peacekeeping missions. [7]

Vaccines

Covishield (2021) K (cropped).jpg
A vial of Covishield, the Indian-manufactured version of the AstraZeneca vaccine.
Bharat Biotech Covaxin Bangalore BESTpedia.jpg
A vial of Covaxin

India has two approved COVID-19 vaccines: Covishield and Covaxin. Both of them were exported and used in foreign grants by the Government of India.

Covishield

On 1 January 2021, the Drug Controller General of India, approved the emergency or conditional use of Covishield. [8] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech. [9]

Covaxin

On 2 January 2021, Covaxin India's first COVID-19 vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage. [10]

Vaccine supply

India kicked off international shipment of the vaccines on 20 January 2021, only four days after starting its own vaccination program. [11] Bhutan and Maldives were the first countries to receive vaccines as a grant by India. This was quickly followed by shipments to Nepal, Bangladesh, Myanmar and Seychelles. [11] By mid-March 2021, India was also supplying vaccines on a commercial basis to countries including Canada, [12] the UK, [13] and Saudi Arabia. [14]

The Serum Institute of India was selected as a key supplier of cost-effective COVID-19 vaccines to the COVAX initiative, [15] 19.8 million doses of Covishield vaccines were supplied by India to various countries through the initiative. [16]

In May, when COVAX was already short 140 million doses, [17] the Serum Institute announced that it expected to maintain its suspension of vaccine deliveries to COVAX through the end of 2021 [18] due to the second wave of COVID-19 in India [19] and the US ban on export of key raw materials. [20]

Vaccines exported

As of 29 May 2021, India had exported 66.4 million doses including 10.7 million vaccine provided as grant to more than 95 nations. [3]

Recipient Country [2] UnitsReceived dateNotes
Flag of the United Nations.svg  United Nations 300,00027 March 2021200,000 doses for UN peacekeepers as gift, distributed to all UN peacekeeping missions. [21] 100,000 doses for UN Health workers [3]
Flag of Taliban.svg  Afghanistan 968,0007 February 2021 [3] 500,000 doses delivered on 7 February 2021 as grant, another batch of 468,000 doses were delivered under commercial deal by 6 March 2021. [3]
Flag of Albania.svg  Albania 50,00016 April 2021 [22] delivered as grant
Flag of Algeria.svg  Algeria 50,00031 January 2021 [3]
Flag of Angola.svg  Angola 624,0001 March 2021 [3]
Flag of Antigua and Barbuda.svg  Antigua and Barbuda 40,00027 February 2021 [3]
Flag of Argentina.svg  Argentina 580,00016 February 2021 [3]
Flag of the Bahamas.svg  Bahamas 20,00010 March 2021 [23]
Flag of Bahrain.svg  Bahrain 100,00028 January 2021 [3]
Flag of Bangladesh.svg  Bangladesh 10,300,000 [3] [24] 21 January 2021
25 January 2021
22 February 2021
Total 3,300,000 doses were delivered as gift, first batch delivered on 21 January 2021. [3] 7,000,000 doses from commercial deal delivered as two batches with first batch of 5,000,000 on 25 January 2021 and second batch of 2,000,000 on 22 February 2021.[ citation needed ]
Flag of Barbados.svg  Barbados 100,0007 February 2021 [3]
Flag of Belize.svg  Belize 25,0007 March 2021 [3]
Flag of Benin.svg  Benin 144,0008 March 2021 [3]
Flag of Bhutan.svg  Bhutan 550,00020 January 2021The start of Vaccine Maitri, [25] as of 21 March 2021 550,000 doses were delivered as grant in two batches [3]
Bandera de Bolivia (Estado).svg  Bolivia 280,00018 March 2021 [3]
Flag of Botswana.svg  Botswana 30,0007 March 2021 [3] Grant
Flag of Brazil.svg  Brazil 4,000,00022 January 2021 [3] Delivered in two batches 0f 2,000,000 doses each, final delivery was on 22 February 2021 [3]
Flag of Cambodia.svg  Cambodia 324,0002 March 2021 [3]
Flag of Cameroon.svg  Cameroon 391,20012 April 2021 [3]
Flag of the Comoros.svg  Comoros 12,00011 April 2021 [3]
Flag of Canada (Pantone).svg  Canada 500,0002 March 2021 [3] Canada was the first G7 country to receive vaccines under this initiative. [26]
Flag of Cape Verde.svg  Cape Verde 24,0009 March 2021 [3]
Flag of Djibouti.svg  Djibouti 24,0005 March 2021 [3]
Flag of Dominica.svg  Dominica 70,0007 Febrruary 2021 [3] Grant
Flag of the Dominican Republic.svg  Dominican Republic 50,00014 February 2021 [3] Delivered as two batches, first batch of 20,000 delivered on 14 February 2021, second batch of 30,000 doses were delivered on 18 February 2021 as grant [3]
Flag of the Democratic Republic of the Congo.svg  Democratic Republic of the Congo 1,766,0001 March 2021 [3] First batch of 1,716,000 delivered as part of the commercial deal on 1 March 2021, another batch of 50,000 doses delivered as grant on 4 March 2021 [3]
Flag of Egypt.svg  Egypt 50,00030 January 2021 [3]
Flag of El Salvador.svg  El Salvador 20,00015 February 2021 [3]
Flag of Ethiopia.svg  Ethiopia 2,184,0007 March 2021 [3]
Flag of Eswatini.svg  Eswatini 32,0009 March 2021 [3] Delivered in two batches first batch of 20,000 doses delivered as grant on 9 March 2021, while 12,000 doses (commercial order) were delivered as second batch on 11 March 2021 [3]
Flag of Fiji.svg  Fiji 100,00026 March 2021 [3] [27] Grant
Flag of The Gambia.svg  Gambia 36,0001 March 2021 [3]
Flag of Ghana.svg  Ghana 652,00023 February 2021[ citation needed ]600,000 doses delivered as part of the COVAX scheme on 23 February 2021, 50,000 doses delivered as grant on 4 March 2021, another batch of 2000 doses delivered on 10 March 2021 (commercial deal) [3]
Flag of Guatemala.svg  Guatemala 200,0002 March 2021 [3] Grant
Flag of Guinea.svg  Guinea 194,40010 April 2021 [3]
Flag of Guinea-Bissau.svg  Guinea-Bissau 28,80010 April 2021 [3]
Flag of Guyana.svg  Guyana 80,0007 March 2021 [3] delivered as grant
Flag of Iran.svg  Iran 125,00010 March 2021 [3] first commercial order for Covaxin [3]
Flag of Cote d'Ivoire.svg  Ivory Coast 554,00025 February 2021 [3] As part of the COVAX scheme 504,000 doses were delivered on 25 February 2021, 50,000 delivered as grant on 4 March 2021. [3]
Flag of Jamaica.svg  Jamaica 50,0005 March 2021delivered as grant [3]
Flag of Kenya.svg  Kenya 1,120,0002 March 2021First batch of 1,020,000 delivered on 2 March 2021 as part of the COVAX initiative, another batch of 100,000 doses delivered as grant on 10 March 2021 [3]
Flag of Kuwait.svg  Kuwait 200,00031 January 2021 [3]
Flag of Laos.svg  Laos 132,00017 March 2021delivered as part of the COVAX initiative [3]
Flag of Lesotho.svg  Lesotho 36,0002 March 2021COVAX initiative [3]
Flag of Liberia.svg  Liberia 96,0004 March 2021COVAX initiative [3]
Flag of Malawi.svg  Malawi 410,0004 March 2021as part of the COVAX initiative first batch of 360,000 doses delivered on 4 March 2021, another batch of 50,000 doses delivered as grant on 12 March 2021 [3]
Flag of Maldives.svg  Maldives 312,00020 January 2021200,000 doses were delivered as grant by 19 February 2021, 100,000 doses were delivered under commercial order, another batch 12,000 doses were delivered as part of the COVAX initiative [3]
Flag of Mali.svg  Mali 396,0003 March 2021COVAX initiative [3]
Flag of Mauritania.svg  Mauritania 69,60012 April 2021COVAX initiative [3]
Flag of Mauritius.svg  Mauritius 400,00019 February 2021100,000 doses delivered as grant on 22 January 2021, 300,000 doses (including 100,000 doses of Covishield vaccine supplied by Serum Institute of India and 200,000 doses of Covaxin supplied by Bharat Biotech) were delivered by 18 March 2021 as two batches. [3]
Flag of Mexico.svg  Mexico 870,00012 February 2021 [3]
Flag of Mongolia.svg  Mongolia 150,00021 February 2021delivered as grant [3]
Flag of Morocco.svg  Morocco 7,000,00022 January 2021
11 February 2021
24 February 2021[ citation needed ]
delivered as three batches [3]
Flag of Mozambique.svg  Mozambique 484,0007 March 2021100,000 doses delivered as grant and 384,000 doses delivered as part of the COVAX initiative on 7 March 2021 [3]
Flag of Myanmar.svg  Myanmar 3,700,00022 January 20211,700,000 doses (including 1,500,000 doses of Covishield and 200,000 doses of Covaxin) were delivered as grant by 11 February 2021, another batch of 2,000,000 doses were delivered under commercial deal on the same day. [3]
Flag of Namibia.svg  Namibia 30,00018 March 2021delivered as grant [3]
Flag of Nauru.svg  Nauru 10,0006 April 2021delivered as grant [3]
Flag of Nepal.svg    Nepal 2,448,00021 January 20211,100,000 doses were delivered as grant (first batch of 1,000,000 on 21 January 2021 and second batch of 100,000 on 28 March 2021), 1,000,000 doses were delivered under commercial order on 20 February 2021, another batch of 348,000 doses were delivered as part of the COVAX initiative on 5 March 2021. [3]
Flag of Nicaragua.svg  Nicaragua 335,0005 March 2021200,000 doses were delivered as grant on 5 March 2021, 135,000 doses were delivered on 14 March 2021 as part of the COVAX initiative [3]
Flag of Niger.svg  Niger 380,00028 March 202125,000 doses delivered as grant on 28 March 2021, another batch of 355,000 doses were delivered as part of the COVAX initiative on 12 April 2021 [3]
Flag of Nigeria.svg  Nigeria 4,024,0001 March 2021 [28] as part of the COVAX initiative 3,924,000 doses were delivered on 1 March 2021, another batch of 100,000 doses were delivered as grant by 25 March 2021 [3]
Flag of Oman.svg  Oman 100,00030 January 2021delivered as grant [3]
Flag of the Seychelles.svg  Seychelles 50,000
Flag of Sri Lanka.svg  Sri Lanka 1,000,000
Flag of South Africa.svg  South Africa 1,000,0001 February 2021 [29] Vaccine Suspended due to 501Y.V2 and sold to African Union Members.
Flag of the United Arab Emirates.svg  United Arab Emirates 200,000
Flag of Saudi Arabia.svg  Saudi Arabia 3,000,000
Flag of Serbia.svg  Serbia 150,00021 February 2021[ citation needed ]
Flag of Ukraine.svg  Ukraine 500,000
Flag of Saint Lucia.svg  Saint Lucia 25,000
Flag of Saint Kitts and Nevis.svg  Saint Kitts and Nevis 20,000
Flag of Saint Vincent and the Grenadines.svg  Saint Vincent and the Grenadines 40,000
Flag of Suriname.svg  Suriname 50,000
Flag of Rwanda.svg  Rwanda 240,000
Flag of Senegal.svg  Senegal 324,000
Flag of Uzbekistan.svg  Uzbekistan 660,00017 March 2021

International reaction

International organizations

Countries

Leaders who received vaccines provided by India

See also

Related Research Articles

Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company. It is the world's largest manufacturer of vaccines located in the city of Pune, India and was founded by Cyrus Poonawalla in 1966. The company is a subsidiary of the holding company Cyrus Poonawalla Group.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Telangana. The first case was recorded in this region on 2 March from a man who had travel history with the UAE.

Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed in the United Kingdom by the Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant, and 61% against the Delta variant.

Vaccine diplomacy Use of vaccines

Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.

COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by Gavi, the Vaccine Alliance, the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO). It is one of the three pillars of the Access to COVID-19 Tools Accelerator, an initiative begun in April 2020 by the WHO, the European Commission, and the government of France as a response to the COVID-19 pandemic. COVAX coordinates international resources to enable low-to-middle-income countries equitable access to COVID-19 tests, therapies, and vaccines. UNICEF is the key delivery partner, leveraging its experience as the largest single vaccine buyer in the world and working on the procurement of COVID-19 vaccine doses, as well logistics, country readiness and in-country delivery.

The COVID-19 vaccination program in the Philippines is an ongoing mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in India Immunisation programme against COVID-19 in India

India began administration of COVID-19 vaccines on 16 January 2021. As of 7 November 2021, India has administered over 1.08 billion doses overall, including first and second doses of the currently-approved vaccines. In India, nearly half the eligible population has got at least one shot, and 19 per cent received both nine months after the vaccine rollout.

European Commission–AstraZeneca COVID-19 vaccine dispute Dispute between the European Union and AstraZeneca

A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol. Vaccination proceeded apace in the UK but more slowly in the EU, and by the end of March 2021, over 30% of the UK population had received at least one dose of vaccine compared to about 8% of the EU population. This was partly due to limited availability of the AstraZeneca vaccine in the EU. The World Health Organization and the European Medicines Agency continued to state that the vaccine was safe and effective. However, a representative of the European Medicines Agency said in June that vaccines based on the mRNA technology should be preferred if available for all age groups, including for the over 60s.

COVID-19 vaccination in Albania

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

The COVID-19 vaccination in Morocco is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Vietnam Plan to immunize against COVID-19 in Vietnam

The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. Sinopharm COVID-19 vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine, Moderna COVID-19 vaccine and Janssen COVID-19 vaccine were approved on 12 June 2021, 29 June 2021, and 15 July 2021, respectively. Vietnam approved Abdala vaccine from Center for Genetic Engineering and Biotechnology on 18 September 2021.

COVID-19 vaccination in Nigeria Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 8 October 2021, 5,118,422 people have received their first dose a COVID-19 vaccine, and 2,359,781 people have received their second dose.

COVID-19 vaccination in Bangladesh

Bangladesh began the administration of COVID-19 vaccines on 27 January 2021 while mass vaccination started on 7 February 2021.

COVID-19 vaccination in Brazil

The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.

COVID-19 vaccination in Nepal Immunisation programme against COVID-19 in Nepal

Nepal began administration of COVID-19 vaccines on 27 January 2021. 1 million Oxford-Astrazeneca vaccines were provided by India as a grant while Nepal brought 2 million doses from Serum Institute of India (SII) and was one of the first to receive COVID-19 vaccines. The delivery of the first 1 million doses arrived on 21 February. In March, India's decision to ban exports of vaccines created uncertainty over whether Nepal would be able to continue its vaccinations. By April, SII had only provided half of the 2 million doses for which Nepal had paid in full. A spokesperson for the Indian Ministry of External Affairs rejected the notion of an export ban and said “We will export vaccines taking into account the domestic demand.” By late July, there was still uncertainty in Nepal over when SII would deliver the vaccines that were purchased, although Prime Minister Narendra Modi said India would "resume the supply of vaccines soon."

COVID-19 vaccination in Sri Lanka Plan to immunize against COVID-19

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, Sinopharm's BBIBP-CorV accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date. The United States donated over 1.5 million Moderna COVID-19 vaccine through COVAX.

COVID-19 vaccination in Eswatini is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

References

  1. "Vaccine Maitri: Consignment of covid vaccines airlifted for Guyana, Jamaica". mint. 5 March 2021. Retrieved 27 April 2021.
  2. 1 2 "Vaccine Maitri: A Sanjeevini for the world". The Hindu Business Line . Retrieved 10 March 2021.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 "Ministry of External Affairs – Government of India". Ministry of External Affairs – Government of India.
  4. "Coronavirus: India temporarily halts Oxford-AstraZeneca vaccine exports". BBC News. 24 March 2021. Retrieved 19 May 2021.
  5. "Covid vaccine: India to resume vaccine exports from October". BBC News. 21 September 2021. Retrieved 23 September 2021.
  6. "India Pledges Support To UN To Ensure Syria Gets Covid Vaccines". NDTV.com. Retrieved 23 March 2021.
  7. India's 'gift' to UN peacekeepers: 200,000 Covid vaccine doses, Mint, 26 March 2021.
  8. "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 2 January 2021.
  9. "AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK". AstraZeneca. AstraZeneca. 30 December 2020. Retrieved 2 January 2021.
  10. "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 2 January 2021.
  11. 1 2 Bhattacherjee, Kallol (20 January 2021). "Coronavirus | India begins COVID-19 vaccine shipment for six countries-IN". The Hindu. ISSN   0971-751X . Retrieved 15 March 2021.
  12. "Covid-19: Canada receives 500,000 doses of Covishield vaccine made in India". Hindustan Times. 3 March 2021. Retrieved 15 March 2021.
  13. Acharya, Bhargav (3 March 2021). "UK to receive 10 million AstraZeneca COVID-19 vaccine doses from India's Serum Institute". Reuters. Retrieved 15 March 2021.
  14. Das, Krishna N. (26 January 2021). "Exclusive: Saudi Arabia to get three million AstraZeneca shots in about a week from India". Reuters. Retrieved 15 March 2021.
  15. "WHO-led Covax vaccine scheme agrees to new supply deal with Serum Institute of India". The Indian Express. 3 February 2021. Retrieved 15 March 2021.
  16. "Ministry of External Affairs – Government of India". Ministry of External Affairs – Government of India.
  17. Mazumdar, Tulip (17 May 2021). "India's Covid crisis hits Covax vaccine-sharing scheme". BBC News. Retrieved 19 May 2021.
  18. Findlay, Stephanie; Pilling, David (18 May 2021). "Indian vaccine maker extends freeze on export of Covid jabs". Financial Times. Retrieved 19 May 2021.
  19. "Covid-19: Has India's deadly second wave peaked?". BBC News. 26 May 2021. Retrieved 23 July 2021.
  20. "Why Covid-19 Vaccination in Poorer Nations Has Slowed, Posing Global Risks". The Wall Street Journal. Retrieved 24 April 2021.
  21. "India Sends 2,00,000 COVID-19 Vaccine Doses as Gift for UN Peacekeepers".
  22. 50,000 doza të vaksinës AstraZeneca (in Albanian). Edi Rama Youtube Channel.
  23. "Bahamas gets 20,000 doses of AstraZeneca vaccines from India". The Associate Times. Retrieved 12 March 2021.
  24. "Vaccine Maitri: Bangladesh only country in the world to receive 9 mn vaccine doses; PM Modi to visit Dhaka". Financial Express. 4 March 2021. Retrieved 11 March 2021.
  25. "50 days of vaccine diplomacy with 60 mn doses to 70 countries". The Hindu Business Line. Retrieved 12 March 2021.
  26. "Canada receives first shipment of 5 lakh COVID-19 vaccine doses from Serum Institute". Business Today . Retrieved 11 March 2021.
  27. "Fiji PM Twitter". Frank Bainamarama. Retrieved 29 March 2021.
  28. "Nigeria Receives 'Made In India' Covid-19 Vaccines Under 'Vaccine Maitri'". The Times of India . Retrieved 11 March 2021.
  29. "First AstraZeneca-vaccines arrive in South Africa". The Mail & Guardian. 1 February 2021. Retrieved 20 March 2021.
  30. "India 'at forefront' in fighting COVID-19; 'stands out' in vaccine policy, says IMF's Gita Gopinath". Business Today. Retrieved 12 March 2021.
  31. 1 2 "African, Caribbean nations support India at WTO on COVID-19 vaccine supplies". The Hindu . 4 March 2021. Retrieved 10 March 2021.
  32. "Nepal PM thanks India for coronavirus vaccines". WION. Retrieved 16 July 2021.
  33. "India's 'Vaccine Maitri' initiative earns praise at WTO". The Hindu Business Line . Retrieved 10 March 2021.
  34. Barbados Prime Minister Thanks PM Modi For Supply Of Covid Vaccines, NDTV, 4 March 2021.
  35. "Vaccine Maitri: Tajikistan, Belize, Jamaica Receive 'Made in India' COVID-19 Vaccines". The Eurasian Times . Retrieved 11 March 2021.
  36. "Top Cambodian leaders receive 1st shot of India-made Covid-19 vaccine". Business Standard India. Business Standard. 11 March 2021. Retrieved 11 March 2021.
  37. "Nepal PM KP Sharma Oli receives shot of India-made Covishield Covid vaccine". India Today . Retrieved 11 March 2021.